tm
Seeing Is Believing
tm
Seeing Is Believing
MNPR is currently covered by 4 analysts with an average price target of $33.91. This is a potential upside of $13.81 (68.71%) from yesterday's end of day stock price of $20.1.
Monopar Therapeutics's activity chart (see below) currently has 6 price targets and 15 ratings on display. The stock rating distribution of MNPR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 34.92% with an average time for these price targets to be met of 209.33 days.
Highest price target for MNPR is $22, Lowest price target is $10, average price target is $33.91.
Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 11-Nov-2024. First documented stock forecast 03-Feb-2020.
Currently out of the existing stock ratings of MNPR, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$22
$1.9 (9.45%)
$6
13 days ago
(11-Nov-2024)
5/7 (71.43%)
$5.34 (32.05%)
432
Buy
$10
$-10.1 (-50.25%)
$200
7 months 13 days ago
(11-Apr-2024)
1/3 (33.33%)
$6.15 (159.74%)
196
Buy
$55
1 years 7 months 26 days ago
(29-Mar-2023)
0/1 (0%)
$29.95 (119.56%)
What is MNPR (Monopar Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MNPR (Monopar Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MNPR (Monopar Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MNPR (Monopar Therapeutics)?
Which analyst is the currently most bullish on MNPR (Monopar Therapeutics)?
Which analyst is the currently most reserved on MNPR (Monopar Therapeutics)?
